Quest Diagnostics reported accelerated testing demand across various channels, with volume growth contributing to its improved outlook. The company raised its 2026 revenue and adjusted earnings outlook in connection with the stronger demand. Reporting noted that lower-margin partnerships and higher operational spending could affect the profitability of this growth.
Key facts
Quest Diagnostics attributed the improved 2026 outlook to accelerated testing demand across various channels source
Quest Diagnostics president and CEO Jim Davis discusses how his company is implementing AI to help its patients on 'The Claman Countdown.' source